 | • レポートコード：MRC23Q36165 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、80ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の医療用ラジオアイソトープ市場について調査・分析し、世界の医療用ラジオアイソトープ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（Tc-99m、コバルト-60、ヨウ素ラジオアイソトープ）、用途別セグメント分析（核治療、設備放射線源、診断、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、NRG、IRE、ANSTO、NTP Radioisotopes、China National Nuclear Corporation、Rosatom、Nordion、Eckert & Ziegler Strahlen、Polatomなどが含まれています。 世界の医療用ラジオアイソトープ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、医療用ラジオアイソトープ市場規模を推定する際に考慮しました。本レポートは、医療用ラジオアイソトープの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、医療用ラジオアイソトープに関するビジネス上の意思決定に役立てることを目的としています。 ・医療用ラジオアイソトープ市場の概要 - 医療用ラジオアイソトープのタイプ別セグメント - 世界の医療用ラジオアイソトープ市場規模：タイプ別分析（Tc-99m、コバルト-60、ヨウ素ラジオアイソトープ） - 医療用ラジオアイソトープの用途別セグメント - 世界の医療用ラジオアイソトープ市場規模：用途別分析（核治療、設備放射線源、診断、その他） - 世界の医療用ラジオアイソトープ市場規模予測（2018年-2029年） ・医療用ラジオアイソトープ市場の成長トレンド - 医療用ラジオアイソトープの地域別市場規模（2018年-2029年） - 医療用ラジオアイソトープ市場ダイナミクス - 医療用ラジオアイソトープの業界動向 - 医療用ラジオアイソトープ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：Tc-99m、コバルト-60、ヨウ素ラジオアイソトープ - 世界の医療用ラジオアイソトープのタイプ別市場規模（2018年-2023年） - 世界の医療用ラジオアイソトープのタイプ別市場規模（2024年-2029年） ・用途別セグメント：核治療、設備放射線源、診断、その他 - 世界の医療用ラジオアイソトープの用途別市場規模（2018年-2023年） - 世界の医療用ラジオアイソトープの用途別市場規模（2024年-2029年） ・医療用ラジオアイソトープの地域別市場規模 - 北米の医療用ラジオアイソトープ市場規模（2018年-2029年） - アメリカの医療用ラジオアイソトープ市場規模（2018年-2029年） - ヨーロッパの医療用ラジオアイソトープ市場規模（2018年-2029年） - アジア太平洋の医療用ラジオアイソトープ市場規模（2018年-2029年） - 中国の医療用ラジオアイソトープ市場規模（2018年-2029年） - 日本の医療用ラジオアイソトープ市場規模（2018年-2029年） - 韓国の医療用ラジオアイソトープ市場規模（2018年-2029年） - インドの医療用ラジオアイソトープ市場規模（2018年-2029年） - オーストラリアの医療用ラジオアイソトープ市場規模（2018年-2029年） - 中南米の医療用ラジオアイソトープ市場規模（2018年-2029年） - 中東・アフリカの医療用ラジオアイソトープ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 NRG、IRE、ANSTO、NTP Radioisotopes、China National Nuclear Corporation、Rosatom、Nordion、Eckert & Ziegler Strahlen、Polatom ・アナリストの観点/結論 ・調査方法とデータソース |
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person’s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
Highlights
The global Medical Radioisotopes market was valued at US$ 679.8 million in 2022 and is anticipated to reach US$ 875.2 million by 2029, witnessing a CAGR of 4.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key medical radioisotopes manufacturers include NRG, IRE etc.The top 2 companies hold a share about 40%.Americas is the largest market, with a share about 45%, followed by Europe and APAC with the share about 25% and 23%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Radioisotopes.
The Medical Radioisotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Radioisotopes market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Radioisotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
Segment by Type
Tc-99m
Cobalt-60
Iodine Radioisotopes
Segment by Application
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Radioisotopes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Radioisotopes Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
1.3 Market by Application
1.3.1 Global Medical Radioisotopes Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Nuclear Therapy
1.3.3 Equipment Radioactive Source
1.3.4 Diagnosis
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical Radioisotopes Market Perspective (2018-2029)
2.2 Medical Radioisotopes Growth Trends by Region
2.2.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical Radioisotopes Historic Market Size by Region (2018-2023)
2.2.3 Medical Radioisotopes Forecasted Market Size by Region (2024-2029)
2.3 Medical Radioisotopes Market Dynamics
2.3.1 Medical Radioisotopes Industry Trends
2.3.2 Medical Radioisotopes Market Drivers
2.3.3 Medical Radioisotopes Market Challenges
2.3.4 Medical Radioisotopes Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Radioisotopes Players by Revenue
3.1.1 Global Top Medical Radioisotopes Players by Revenue (2018-2023)
3.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2018-2023)
3.2 Global Medical Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Radioisotopes Revenue
3.4 Global Medical Radioisotopes Market Concentration Ratio
3.4.1 Global Medical Radioisotopes Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Radioisotopes Revenue in 2022
3.5 Medical Radioisotopes Key Players Head office and Area Served
3.6 Key Players Medical Radioisotopes Product Solution and Service
3.7 Date of Enter into Medical Radioisotopes Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Radioisotopes Breakdown Data by Type
4.1 Global Medical Radioisotopes Historic Market Size by Type (2018-2023)
4.2 Global Medical Radioisotopes Forecasted Market Size by Type (2024-2029)
5 Medical Radioisotopes Breakdown Data by Application
5.1 Global Medical Radioisotopes Historic Market Size by Application (2018-2023)
5.2 Global Medical Radioisotopes Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medical Radioisotopes Market Size (2018-2029)
6.2 North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical Radioisotopes Market Size by Country (2018-2023)
6.4 North America Medical Radioisotopes Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical Radioisotopes Market Size (2018-2029)
7.2 Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical Radioisotopes Market Size by Country (2018-2023)
7.4 Europe Medical Radioisotopes Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Radioisotopes Market Size (2018-2029)
8.2 Asia-Pacific Medical Radioisotopes Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical Radioisotopes Market Size by Region (2018-2023)
8.4 Asia-Pacific Medical Radioisotopes Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical Radioisotopes Market Size (2018-2029)
9.2 Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical Radioisotopes Market Size by Country (2018-2023)
9.4 Latin America Medical Radioisotopes Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Radioisotopes Market Size (2018-2029)
10.2 Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023)
10.4 Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NRG
11.1.1 NRG Company Detail
11.1.2 NRG Business Overview
11.1.3 NRG Medical Radioisotopes Introduction
11.1.4 NRG Revenue in Medical Radioisotopes Business (2018-2023)
11.1.5 NRG Recent Development
11.2 IRE
11.2.1 IRE Company Detail
11.2.2 IRE Business Overview
11.2.3 IRE Medical Radioisotopes Introduction
11.2.4 IRE Revenue in Medical Radioisotopes Business (2018-2023)
11.2.5 IRE Recent Development
11.3 ANSTO
11.3.1 ANSTO Company Detail
11.3.2 ANSTO Business Overview
11.3.3 ANSTO Medical Radioisotopes Introduction
11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2018-2023)
11.3.5 ANSTO Recent Development
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Detail
11.4.2 NTP Radioisotopes Business Overview
11.4.3 NTP Radioisotopes Medical Radioisotopes Introduction
11.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023)
11.4.5 NTP Radioisotopes Recent Development
11.5 China National Nuclear Corporation
11.5.1 China National Nuclear Corporation Company Detail
11.5.2 China National Nuclear Corporation Business Overview
11.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction
11.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2018-2023)
11.5.5 China National Nuclear Corporation Recent Development
11.6 Rosatom
11.6.1 Rosatom Company Detail
11.6.2 Rosatom Business Overview
11.6.3 Rosatom Medical Radioisotopes Introduction
11.6.4 Rosatom Revenue in Medical Radioisotopes Business (2018-2023)
11.6.5 Rosatom Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Medical Radioisotopes Introduction
11.7.4 Nordion Revenue in Medical Radioisotopes Business (2018-2023)
11.7.5 Nordion Recent Development
11.8 Eckert & Ziegler Strahlen
11.8.1 Eckert & Ziegler Strahlen Company Detail
11.8.2 Eckert & Ziegler Strahlen Business Overview
11.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
11.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2018-2023)
11.8.5 Eckert & Ziegler Strahlen Recent Development
11.9 Polatom
11.9.1 Polatom Company Detail
11.9.2 Polatom Business Overview
11.9.3 Polatom Medical Radioisotopes Introduction
11.9.4 Polatom Revenue in Medical Radioisotopes Business (2018-2023)
11.9.5 Polatom Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details